Prosecution Insights
Last updated: April 19, 2026

Dyne Therapeutics Inc.

9 pending office actions

Portfolio Summary

9
Total Pending OAs
5
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18024486 METHODS OF PREPARING PROTEIN-OLIGONUCLEOTIDE COMPLEXES HUYNH, PHUONG N 1641 Non-Final OA Mar 02, 2023
18017179 MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES ROSSI, JULIA ANNE LORRAIN 1615 Final Rejection Jan 20, 2023
18017173 MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY YAO, LEI 1642 Non-Final OA Jan 20, 2023
18017182 MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY ROSSI, JULIA ANNE LORRAIN 1615 Non-Final OA Jan 20, 2023
17796418 ANTI-TRANSFERRIN RECEPTOR (TFR) ANTIBODY AND USES THEREOF BERHANE, SELAM 1675 Non-Final OA Jul 29, 2022
17794768 MUSCLE-TARGETING COMPLEXES AND USES THEREOF IN TREATING MUSCLE ATROPHY EMCH, GREGORY S 1678 Final Rejection Jul 22, 2022
17791667 MUSCLE-TARGETING COMPLEXES AND USES THEREOF NOAKES, SUZANNE MARIE 1656 Final Rejection Jul 08, 2022
17791697 MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY YAO, LEI 1642 Final Rejection Jul 08, 2022
17791681 MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING MYOTONIC DYSTROPHY HADDAD, MAHER M 1641 Final Rejection Jul 08, 2022

Managing Dyne Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month